Risiko
Bærekraft
(1 av 3)
🌳
🌳
🌳
Totalpris (det du betaler årlig):
1,43%
Prisdetaljer
Pris for fondet:
1,93%
Plattformavgift:
0,25%
Returprovisjon:
-0,75%
Vis priser med rabatt for Akademikerne Pluss eller Tekna
Avkastning pr. 25.07
Siste måned:
4,7%
Siste 6 måneder:
17,8%
Hittil i år:
23,3%
Siste år:
25,0%
Siste 3 år (per år):
8,6%
Siste 5 år (per år):
12,5%
Morningstar-rating:
3
ISIN:
LU1775982595
Forvaltningskapital:
3 474 221 175 kr
Kategori:
Bransjefond, Helsevern
NAV/Kurs (25.07.2024):
2 248 kr
Obligasjoner:
0,0%
Kontanter:
0,1%
Aksjer:
97,8%
Annet:
2,1%
Startdato:
07.09.2018
10 største eierandeler
Eli Lilly and Co
9,4%
Boston Scientific Corp
5,3%
UnitedHealth Group Inc
5,3%
McKesson Corp
4,2%
Stryker Corp
3,6%
Merck & Co Inc
3,6%
Regeneron Pharmaceuticals Inc
3,6%
Vertex Pharmaceuticals Inc
3,5%
Thermo Fisher Scientific Inc
3,3%
Intuitive Surgical Inc
3,3%
Helse
99,8%
Eiendom
0,2%
Nord-Amerika
89,9%
Europa
9,9%
Asia
0,2%
The Fund aims to achieve long-term capital growth. The Fund seeks to achieve its objective by investing primarily in equity and equity related securities of innovative healthcare companies throughout the world. For the purposes of the Fund, healthcare companies include (but are not limited to) companies in the sectors of pharmaceuticals, biotechnology, healthcare services and medical technology and supplies. The Investment Manager seeks to invest in companies that have the potential to materially improve the quality of care, access to care or cost of care through their innovative approach to products and services, use of technology, processes and business models, or management.